Copyright
©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1692-1703
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1692
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1692
Procedure | Target weight loss | Advantages | Disadvantages | Complications |
Laparoscopic adjustable gastric banding | 20%-25% | No anatomic alteration, removable, adjustable | Erosion, slip, and prolapse | Gastric ptosis, outlet obstruction, erosion of the gastric wall by gastric banding |
Sleeve gastrectomy | 25%-30% | Easy to perform, no anastomosis, reproducible, few long-term complications | Leaks difficult to manage, 20%-30% risk of GERD | Bleeding of the cutting edge, leakage and stenosis |
Roux-en-Y gastric bypass | 30%-35% | Effective for GERD, can be used as second stage after sleeve gastrectomy | Internal hernias possible, long-term micronutrient deficiencies | Anastomotic leakage, bleeding, incisional infection, anastomotic stenosis and malnutrition |
Biliopancreatic diversion with duodenal switch | 35%-45% | Long-lasting weight loss, especially effective in patients with very high BMI | GERD, potential for hernias, technically challenging | Diarrhoea, nutrient deficiency |
Single anastomosisduodeno-ileal bypass with sleeve gastrectomy | 35%-45% | Single anastomosis with strong metabolic effect and low rate of early complications | Nutritional and micronutrient deficiencies possible, duodenal dissection | GERD, bile reflux |
Intragastric balloon | 10%-12% | Endoscopic or swallowed, good safety profile | Temporary (6 months) therapy, early removal rate of 10%-19% | Abdominal pain, nausea and vomiting |
One-anastomosisgastric bypass | 35%-40% | Simpler to perform, strong metabolic effects, no mesenteric defects | Potential for bile reflux, long biliopancreatic limb | Malnutrition, diarrhea |
Transpyloric bulb | 14% | Outpatient endoscopic procedures with long implantation times | Gastric mucosal erosion | Gastric ulcer |
Aspiration therapy | 12%-14% | Endoscopy, treatment is completely reversible | Tube-related problems/complications, 26% early removal | Abdominal pain, gastrostomy site infection |
Vagal nerve blocking therapy | 8%-9% | No anatomic changes, low complication rate | Explant required for conversion to another procedure | Pain at neuroregulatory site, indigestion, nausea |
Gastric electric stimulation | 20%-30% | No anatomical changes, minimal surgical trauma, high surgical safety | Difficulty in determining electrode implantation position and electrical stimulation parameters | Perforation, electrode dislodgement, electrode failure |
Left gastric artery embolization | 3%-14% | No anatomical changes, minimal surgical trauma | Difficulty in selecting embolic materials and target vessels | Ulcer, abdominal pain, and vomiting |
- Citation: He YF, Hu XD, Liu JQ, Li HM, Lu SF. Bariatric surgery and diabetes: Current challenges and perspectives. World J Diabetes 2024; 15(8): 1692-1703
- URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1692.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i8.1692